Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

p2y5, now called LPA6, is a receptor important for human hair growth.

Blocking DKK1 with siRNA can improve hair growth.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

A specific RNA molecule, circCOL1A1, affects the growth and quality of goat hair by interacting with miR-149-5p and influencing cell growth pathways.

D'orenone stops root hair growth by disrupting auxin transport, but adding auxin can reverse this.

Dermal sheath cells help heal wounds by showing both skin and connective tissue traits.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Apremilast did not work for treating severe alopecia areata.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Immune system failure in hair follicles causes lichen planopilaris, leading to hair loss.